RFC
MTNB icon

Regions Financial Corp’s Matinas BioPharma MTNB Stock Holding History

Regions Financial Corp’s Portfolio MTNB Stock Details MTNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-500
Closed -$34K – 875
2020
Q4 		$34K Buy
+500
New +$23.2K ﹤0.01% 819

Other funds holding MTNB

BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Regions Financial Corp's MTNB Position: Q1 2021 in Review

Regions Financial Corp sold out of Matinas BioPharma (MTNB) in Q1 2021, closing a stake of 500 shares — an estimated $34K sold.

Regions Financial Corp first reported a position in MTNB in Q4 2020 and held it in 1 quarter. The position peaked at $34K in Q4 2020. 80 funds tracked by Wall St. Rank hold MTNB as of Q1 2021.

  • Regions Financial Corp reported no remaining Matinas BioPharma position as of Q1 2021 after selling out during the quarter.
  • Regions Financial Corp sold 500 Matinas BioPharma shares in Q1 2021, an estimated $34K.
  • Regions Financial Corp first reported a position in Matinas BioPharma in Q4 2020 and held it in 1 quarter.
  • Regions Financial Corp's Matinas BioPharma position peaked at $34K in Q4 2020.
  • 80 funds tracked by Wall St. Rank held Matinas BioPharma as of Q1 2021.

Based on Regions Financial Corp's 13F filing for Q1 2021, filed 2 Jun 2021.